SUBMISSION DEADLINE: JUNE 17, 2026
The ACMG Nominations Committee developes a slate of candidates from the nominations received by the membership. ACMG Fellow members may self-nominate. To be considered for candidacy the Nominee must complete this form in full.
Eligibilty: To apply you must be an ACMG Fellow Member (MD, DO, or PhD) and previous ACMG volunteer service is a prerequisite. Physician Fellows must also be AMA members.
Note: A director of the College may not concurrently serve as a College employee, or as an officer, director, or employee of the American Society of Human Genetics, the American Board of Medical Genetics and Genomics, the Society for Inherited Metabolic Disorders, the Association for Molecular Pathology or any other national or international professional organization that the Board of Directors deems to present a potential conflict with the Director’s service to the College.
The Nominations Committee strives to bring forward a diverse and equitable slate of candidates. We encourage anyone meeting the prerequisites above to apply.
ACMG Board of Directors Role and Time Commitment
The following ACMG Board of Directors seats are up for election this year:
One (1) President-Elect Seat
Eligibility: Any Fellow in good standing (MD, DO, or PhD) of the College is eligible to run for President-Elect. Physician Fellows must also be AMA members.
Term: Six years total: 2027 - 2033 (as President from 2029 - 2031).
Number of Candidates Needed:
One (1) President-Elect to fill the seat that will be vacated by Christa Lese Martin, PhD, FACMG
Four (4) Director Seats
Eligibility: Any Fellow in good standing (MD, DO, or PhD) of the College is eligible to run for the Board of Directors. Physician Fellows must also be AMA members.
Term: Six years: 2027 – 2033
Number of Candidates Needed:
Two (Two (2) - Director Clinical Biochemical Genetics to fill the seat vacated by Jerry Vockely, MD,PhD, FACMG
2) - Director Clinical Clinical Genetics to fill the seat vacated by Shweta Dhar, MD, MS, FACMG
Two (2) - Director Clinical Genetics to fill the seat vacated by David Stevenson, MD, FACMG
Two (2) - Director Clinical Cytogenetics to fill the seat vacated by Hutton M. Kearney, Phd, FACMG